Eveningness O
among O
late O
adolescent O
males O
predicts O
neural O
reactivity O
to O
reward O
and O
alcohol O
dependence O
two O
years O
later O
Eveningness O
, O
a O
preference O
for O
later O
sleep-wake O
timing O
, O
is O
linked O
to O
altered O
reward O
function O
, O
which O
may O
explain O
a O
consistent O
association O
with O
substance O
abuse O
. O

Notably O
, O
the O
extant O
literature O
rests O
largely O
on O
cross-sectional O
data O
, O
yet O
both O
eveningness O
and O
reward O
function O
show O
developmental O
changes O
. O

We O
examined O
whether O
circadian O
preference O
during O
late O
adolescence O
predicted O
the O
neural O
response O
to O
reward O
two O
years O
later O
. O

A O
sample O
of O
93 O
males O
reported O
circadian O
preference O
and O
completed O
a O
monetary O
reward O
fMRI O
paradigm O
at O
ages O
20 O
and O
22 O
. O

Primary O
analyses O
examined O
longitudinal O
paths O
from O
circadian O
preference O
to O
medial O
prefrontal O
cortex O
( O
mPFC O
) O
and O
ventral O
striatal O
( O
VS O
) O
reward O
responses O
. O

We O
also O
explored O
whether O
reward O
responses O
mediated O
longitudinal O
associations O
between O
circadian O
preference O
and O
alcohol O
dependence O
, O
frequency O
of O
alcohol O
use O
, O
and/or O
frequency O
of O
cannabis O
use O
. O

Age O
20 O
eveningness O
was O
positively O
associated O
with O
age O
22 O
mPFC O
and O
VS O
responses O
to O
win O
, O
but O
not O
associated O
with O
age O
22 O
reactivity O
to O
reward O
anticipation O
. O

Age O
20 O
eveningness O
was O
indirectly O
related O
to O
age O
22 O
alcohol O
dependence O
via O
age O
22 O
mPFC O
response O
to O
win O
. O

Our O
findings O
provide O
novel O
evidence O
that O
altered O
reward-related O
brain O
function O
could O
underlie O
associations O
between O
eveningness O
and O
alcohol O
use O
problems O
. O

Eveningness O
may O
be O
an O
under-recognized O
but O
modifiable O
risk O
factor O
for O
reward-related O
problems O
such O
as O
mood O
and O
substance O
use O
disorders O
. O

2 O
. O

METHODS O
AND O
MATERIALS O
2.1 O
Participants O
Participants O
were O
drawn O
from O
the O
Pitt O
Mother O
& O
Child O
Project O
( O
PMCP O
) O
, O
an O
ongoing O
longitudinal O
study O
examining O
vulnerability O
and O
resilience O
in O
low-income O
boys O
. O

The O
initial O
sample O
consisted O
of O
310 O
boys O
and O
their O
families O
, O
recruited O
when O
boys O
were O
6 O
to O
17 O
months O
old O
through O
Women O
, O
Infants O
, O
and O
Children O
Nutritional O
Supplement O
( O
WIC O
) O
programs O
serving O
low-income O
families O
in O
the O
Pittsburgh O
metropolitan O
area O
( O
see O
. O

The O
current O
study O
utilizes O
data O
from O
subsequent O
laboratory O
visits O
when O
participants O
were O
20 O
and O
22 O
years O
of O
age O
. O

These O
visits O
each O
included O
a O
clinical O
interview O
, O
self-report O
measures O
, O
and O
an O
fMRI O
scan O
. O

Written O
informed O
consent O
was O
obtained O
for O
all O
participants O
. O

The O
study O
was O
approved O
by O
the O
Institutional O
Review O
Board O
of O
the O
University O
of O
Pittsburgh O
. O

Participants O
were O
asked O
to O
refrain O
from O
using O
any O
illegal O
substances O
starting O
48 O
h O
prior O
to O
their O
fMRI O
scan O
and O
all O
participants O
were O
approved O
for O
the O
scan O
by O
a O
registered O
nurse O
. O

A O
combination O
of O
breathalyzer O
, O
saliva O
drug O
screen O
, O
self-report O
, O
and O
clinical O
judgment O
were O
used O
to O
determine O
which O
participants O
were O
approved O
to O
scan O
. O

A O
total O
of O
106 O
participants O
had O
circadian O
preference O
data O
at O
both O
age O
20 O
and O
22 O
. O

Of O
these O
, O
a O
total O
of O
93 O
participants O
had O
valid O
reward O
task O
fMRI O
data O
at O
both O
ages O
( O
5 O
were O
excluded O
because O
of O
scheduling O
limitations O
, O
2 O
were O
excluded O
because O
of O
claustrophobia O
, O
2 O
were O
excluded O
because O
of O
metal/bullet O
fragments O
, O
2 O
were O
excluded O
because O
of O
inadequate O
coverage O
of O
the O
ventral O
striatum O
, O
1 O
was O
excluded O
because O
of O
misunderstanding O
the O
task O
, O
and O
1 O
refused O
the O
scan O
) O
. O

2.2 O
Clinical O
measures O
Circadian O
preference O
We O
used O
the O
Composite O
Scale O
of O
Morningness O
to O
assess O
circadian O
preference O
at O
the O
age O
20 O
and O
22 O
assessments O
( O
age O
20 O
α=0.63 O
; O
age O
22 O
α=0.65 O
) O
. O

The O
score O
is O
obtained O
by O
the O
sum O
of O
13 O
Likert-type O
items O
, O
and O
ranges O
from O
13 O
( O
extreme O
eveningness O
) O
to O
55 O
( O
extreme O
morningness O
) O
. O

Although O
we O
used O
the O
CSM O
score O
as O
a O
continuous O
measure O
for O
the O
primary O
analyses O
, O
for O
descriptive O
purposes O
we O
also O
classified O
participants O
by O
type O
using O
the O
scoring O
thresholds O
suggested O
by O
Natale O
and O
Alzani O
: O
13–26=evening-type O
; O
27–41=intermediate-type O
; O
42–55=morning-type O
. O

Alcohol O
dependence O
We O
used O
the O
age O
22 O
administration O
of O
the O
Alcohol O
Dependence O
Scale O
( O
ADS O
) O
, O
a O
25-item O
questionnaire O
to O
assess O
self-reported O
alcohol O
withdrawal O
symptoms O
, O
impaired O
control O
over O
drinking O
, O
awareness O
of O
a O
compulsion O
to O
drink O
, O
increased O
tolerance O
to O
alcohol O
, O
and O
salience O
of O
drink-seeking O
behavior O
in O
the O
past O
year O
. O

A O
score O
of O
9 O
or O
more O
is O
highly O
indicative O
of O
current O
diagnosis O
of O
alcohol O
abuse O
or O
dependence O
( O
α=0.78 O
for O
sample O
) O
. O

Because O
the O
ADS O
was O
administered O
only O
to O
participants O
reporting O
current O
alcohol O
use O
at O
age O
20 O
( O
n=70 O
in O
the O
present O
sample O
) O
, O
we O
elected O
to O
focus O
only O
on O
age O
22 O
ADS O
scores O
in O
the O
primary O
analyses O
. O

Alcohol O
use O
We O
assessed O
frequency O
of O
alcohol O
use O
via O
the O
age O
20 O
and O
22 O
administrations O
of O
the O
Lifetime O
Drinking O
History O
, O
a O
structured O
interview O
designed O
to O
quantify O
lifetime O
patterns O
of O
the O
use O
of O
alcohol O
. O

Participants O
reported O
on O
past O
year O
frequency O
of O
alcohol O
( O
days O
per O
month O
) O
. O

Based O
on O
the O
skewed O
distribution O
of O
alcohol O
use O
data O
, O
we O
used O
a O
square-root O
transformation O
. O

Cannabis O
use O
Although O
we O
did O
not O
have O
a O
measure O
of O
cannabis O
problems O
parallel O
to O
the O
ADS O
, O
we O
assessed O
frequency O
of O
cannabis O
use O
via O
the O
age O
20 O
and O
22 O
administrations O
of O
the O
Lifetime O
Drug O
Use O
History O
, O
a O
structured O
interview O
designed O
to O
quantify O
lifetime O
patterns O
of O
the O
use O
of O
various O
substances O
. O

Participants O
reported O
on O
past O
year O
frequency O
of O
cannabis O
use O
( O
days O
per O
month O
) O
. O

Based O
on O
the O
bimodal O
distribution O
of O
the O
cannabis O
use O
data O
, O
we O
created O
an O
ordinal O
version O
of O
the O
variable O
( O
0=no O
days O
per O
month O
, O
1=1–19 O
days O
per O
month O
, O
3=20+ O
days O
per O
month O
) O
with O
a O
unimodal O
distribution O
( O
n O
= O
39 O
, O
37 O
, O
and O
13 O
, O
respectively O
) O
for O
use O
in O
the O
analyses O
. O

Tobacco O
use O
We O
also O
assessed O
daily O
tobacco O
use O
given O
because O
it O
is O
associated O
with O
decreased O
reward-related O
brain O
function O
. O

We O
used O
the O
8-point O
Likert-scale O
tobacco O
use O
item O
from O
the O
age O
22 O
administration O
of O
the O
Alcohol O
and O
Drug O
Consumption O
Questionnaire O
, O
dichotomizing O
the O
item O
into O
no O
daily O
use O
( O
scores O
= O
0–7 O
) O
and O
daily O
use O
( O
score=8 O
) O
. O

Depressive O
symptoms O
We O
used O
the O
Beck O
Depression O
Inventory O
( O
BDI O
) O
to O
assess O
depressive O
symptomatology O
at O
age O
20 O
and O
22 O
, O
given O
prior O
reports O
that O
depression O
is O
associated O
with O
both O
eveningness O
and O
altered O
reward-related O
brain O
function O
. O

Psychopathology O
Finally O
, O
at O
age O
22 O
, O
we O
assessed O
current O
and O
past O
Axis O
I O
clinical O
disorders O
using O
the O
SCID O
with O
a O
clinically O
trained O
staff O
person O
trained O
to O
reliability O
with O
a O
licensed O
clinical O
psychologist O
. O

For O
descriptive O
purposes O
, O
we O
provide O
information O
on O
Major O
Depressive O
Disorder O
, O
Dysthymia O
, O
Bipolar O
Disorder O
, O
Alcohol O
Dependence O
, O
Substance O
Dependence O
, O
and O
Antisocial O
Personality O
Disorder O
given O
their O
relevance O
to O
reward O
function O
. O

At O
age O
22 O
, O
11 O
% O
had O
a O
history O
of O
Major O
Depressive O
Disorder O
, O
1 O
% O
had O
a O
history O
of O
Bipolar O
Disorder O
, O
5 O
% O
had O
a O
history O
of O
Dysthmia O
, O
2 O
% O
had O
a O
history O
of O
Alcohol O
Dependence O
, O
2 O
% O
had O
a O
history O
of O
non-alcohol O
Substance O
Dependence O
, O
and O
7 O
% O
had O
a O
history O
of O
Antisocial O
Personality O
Disorder O
. O

2.3 O
Reward O
processing O
task O
We O
employed O
a O
slow O
event-related O
fMRI O
card-guessing O
paradigm O
designed O
to O
examine O
neural O
reactivity O
to O
anticipation O
and O
receipt O
of O
monetary O
reward O
and O
loss O
see O
) O
. O

Trials O
were O
presented O
in O
a O
pseudorandom O
order O
with O
predetermined O
outcomes O
. O

Each O
20-s O
trial O
consisted O
of O
a O
4-s O
decision O
phase O
when O
participants O
guessed O
whether O
the O
value O
of O
a O
visually O
presented O
card O
with O
a O
possible O
value O
of O
1–9 O
was O
higher O
or O
lower O
than O
5 O
, O
a O
6-s O
anticipation O
period O
when O
the O
trial O
type O
( O
possible-reward O
or O
possible-loss O
) O
was O
displayed O
, O
a O
1–s O
outcome O
period O
the O
numerical O
value O
of O
the O
card O
and O
then O
outcome O
feedback O
( O
win O
, O
loss O
, O
or O
no-change O
) O
were O
presented O
, O
and O
a O
9-s O
interstimulus O
interval O
. O

In O
reward O
trials O
participants O
would O
win O
$ O
1 O
if O
their O
guess O
was O
correct O
and O
there O
would O
be O
no-change O
in O
earnings O
if O
their O
guess O
was O
incorrect O
. O

In O
loss O
trials O
participants O
would O
lose O
50 O
cents O
if O
their O
guess O
was O
incorrect O
and O
there O
would O
be O
no-change O
in O
earnings O
if O
their O
guess O
was O
correct O
. O

Twenty-four O
trials O
were O
presented O
in O
one O
run O
with O
12 O
reward-anticipation O
and O
12 O
loss-anticipation O
trials O
. O

Within O
reward-anticipation O
trials O
there O
were O
a O
balanced O
number O
of O
win-outcome O
and O
no-change O
outcome O
trials O
. O

In O
the O
present O
study O
we O
focus O
on O
the O
anticipation O
and O
outcome O
phases O
of O
the O
reward O
trials O
, O
based O
on O
evidence O
that O
circadian O
preference O
is O
more O
strongly O
related O
to O
reward O
, O
appetitive O
motivation O
, O
and O
positive O
affect O
than O
to O
negative O
affect O
processes O
, O
and O
specifically O
used O
the O
reward O
anticipation O
> O
baseline O
and O
reward O
win O
> O
baseline O
contrasts O
, O
in O
which O
baseline O
was O
defined O
as O
the O
last O
3 O
s O
of O
the O
interstimulus O
interval O
. O

Outcome O
probabilities O
were O
fixed O
trial-wise O
to O
ensure O
an O
identical O
win/loss O
time O
series O
modeling O
and O
pattern O
of O
outcome O
experiences O
for O
every O
participant O
. O

Each O
participant O
was O
given O
$ O
10 O
in O
earnings O
. O

Participants O
were O
unaware O
of O
the O
fixed O
outcome O
probabilities O
in O
the O
paradigm O
, O
and O
were O
led O
to O
believe O
their O
performance O
would O
determine O
net O
monetary O
gain O
. O

Neuroimaging O
data O
were O
collected O
using O
a O
3.0 O
T O
Siemens O
Trio O
MRI O
scanner O
at O
the O
University O
of O
Pittsburgh O
. O

Structural O
3D O
axial O
MPRAGE O
images O
were O
acquired O
in O
the O
same O
session O
( O
TE=3.29 O
ms O
; O
TR=2200 O
ms O
; O
Flip O
Angle=9° O
; O
Field O
of O
View=256 O
× O
192 O
mm2 O
; O
Slice-Thickness=1 O
mm O
; O
Matrix O
: O
256 O
× O
256 O
; O
192 O
continuous O
slices O
) O
. O

Mean O
blood-oxygenation-level-dependent O
( O
BOLD O
) O
images O
were O
then O
acquired O
with O
a O
gradient O
echo O
EPI O
sequence O
during O
13-min O
covering O
39 O
axial O
slices O
( O
3.1 O
mm O
thick O
; O
TR/TE=2000/28 O
ms O
; O
FOV=205×205 O
mm O
; O
matrix O
64 O
× O
64 O
; O
Flip O
Angle O
90° O
) O
. O

2.4 O
fMRI O
preprocessing O
and O
initial O
analyses O
Neuroimaging O
data O
were O
preprocessed O
and O
analyzed O
with O
Statistical O
Parametric O
Mapping O
software O
, O
Version-8 O
( O
SPM8 O
; O
http O
: O
//www.fil.ion.ucl.ac.uk/spm O
) O
. O

Data O
for O
each O
participant O
were O
realigned O
to O
the O
first O
volume O
in O
the O
time O
series O
to O
correct O
for O
head O
motion O
. O

Data O
sets O
were O
then O
selected O
for O
quality O
based O
on O
our O
standard O
small-motion O
correction O
( O
< O
2 O
mm O
on O
average O
across O
all O
frames O
) O
and O
adequate O
coverage O
of O
the O
ventral O
striatum O
( O
> O
80 O
% O
) O
. O

Realigned O
images O
were O
then O
coregistered O
with O
the O
subject O
’ O
s O
anatomical O
image O
, O
segmented O
to O
restrict O
analyses O
to O
gray O
matter O
, O
normalized O
to O
standard O
Montreal O
Neurological O
Institute O
( O
MNI O
) O
template O
, O
and O
spatially O
smoothed O
with O
a O
Gaussian O
kernel O
of O
6 O
mm O
full-width O
at O
half-maximum O
. O

A O
first-level O
fixed-effect O
model O
was O
constructed O
for O
each O
participant O
and O
scan O
and O
predetermined O
condition O
effects O
at O
each O
voxel O
were O
calculated O
using O
a O
t-statistic O
, O
producing O
a O
statistical O
image O
for O
the O
reward-anticipation- O
minus-baseline O
and O
win-outcome-after-reward-anticipation-minus-baseline O
contrast O
. O

First-level O
contrast O
images O
were O
then O
included O
in O
second-level O
whole-brain O
and O
region O
of O
interest O
( O
ROI O
) O
analyses O
. O

The O
VS O
ROI O
was O
constructed O
using O
the O
WFU O
Pickatlas O
Tool O
( O
v1.04 O
) O
and O
defined O
as O
a O
sphere O
20mm O
in O
radius O
, O
centered O
on O
the O
ventral O
striatum O
using O
Talairach O
coordinates O
x=0 O
, O
y=10 O
, O
and O
z=−10 O
, O
and O
encompassing O
the O
head O
of O
the O
caudate O
nucleus O
and O
ventral O
areas O
. O

The O
mPFC O
ROI O
was O
constructed O
using O
the O
PickAtlas O
and O
defined O
as O
a O
5393-voxel O
sphere O
including O
medial O
Brodmann O
Area O
( O
BA O
) O
10 O
and O
BA32 O
, O
key O
projection O
targets O
of O
midbrain O
dopamine O
neurons O
, O
which O
demonstrate O
connectivity O
with O
the O
ventral O
striatum O
, O
and O
which O
have O
been O
implicated O
in O
evaluating O
the O
relative O
value O
of O
rewards O
and O
reward-directed O
behavior O
. O

At O
the O
second O
level O
, O
we O
used O
1-sample O
t-tests O
in O
the O
age O
20 O
sample O
to O
ascertain O
the O
main O
effect O
of O
task O
( O
anticipation-baseline O
and O
win-baseline O
contrasts O
) O
in O
each O
ROI O
, O
using O
a O
height O
threshold O
of O
p O
< O
0.001 O
and O
a O
cluster-level O
threshold O
of O
pFWE O
< O
0.05 O
. O

A O
single O
cluster O
was O
identified O
in O
each O
of O
the O
VS O
and O
mPFC O
ROIs O
. O

To O
focus O
on O
voxels O
within O
each O
ROI O
responsive O
to O
the O
reward O
task O
, O
we O
created O
functional O
masks O
based O
on O
these O
VS O
and O
mPFC O
clusters O
( O
see O
Figures O
S1 O
and O
S2 O
in O
the O
Supplement O
) O
, O
and O
then O
employed O
the O
Marsbar O
toolbox O
to O
extract O
the O
mean O
activation O
across O
each O
functional O
cluster O
in O
both O
the O
age O
20 O
and O
age O
22 O
datasets O
. O

These O
mean O
activations O
across O
VS O
and O
mPFC O
were O
subsequently O
used O
in O
all O
remaining O
analyses O
. O

We O
examined O
the O
distribution O
of O
the O
extracted O
ROI O
data O
, O
excluding O
4 O
participants O
with O
values O
greater O
than O
3SD O
from O
the O
mean O
, O
resulting O
in O
a O
sample O
of O
89 O
participants O
. O

Also O
, O
based O
on O
prior O
evidence O
of O
circadian O
rhythms O
in O
reward O
processes O
, O
including O
reward-related O
brain O
activation O
( O
, O
) O
, O
we O
explored O
correlations O
between O
the O
extracted O
ROI O
data O
and O
the O
time O
of O
scan O
( O
which O
ranged O
from O
9AM–4PM O
) O
. O

There O
were O
no O
significant O
correlations O
between O
extracted O
ROI O
data O
and O
the O
time O
of O
scan O
, O
and O
thus O
time O
of O
scan O
was O
not O
used O
as O
a O
covariate O
in O
subsequent O
analyses O
. O

2.5 O
Main O
data O
analyses O
Changes O
in O
circadian O
preference O
, O
substance O
outcomes O
, O
and O
reward-related O
brain O
function O
were O
examined O
via O
paired-sample O
t-tests O
or O
the O
Wilcoxon O
Signed O
Ranks O
Test O
( O
cannabis O
use O
only O
) O
. O

Fisher O
’ O
s O
Exact O
Test O
( O
FET O
) O
was O
used O
to O
examine O
changes O
in O
distribution O
of O
circadian O
preference O
types O
. O

Hypothesized O
associations O
between O
circadian O
preference O
, O
reward-related O
brain O
function O
, O
and O
substance O
use O
were O
initially O
examined O
via O
bivariate O
Pearson O
’ O
s O
correlations O
in O
SPSS O
22 O
( O
IBM O
Corporation O
, O
2013 O
) O
. O

Significant O
relationships O
were O
subsequently O
evaluated O
using O
cross-lag O
panel O
and O
mediation O
analyses O
in O
Mplus O
7 O
. O

Cross-lag O
panel O
analyses O
with O
maximum O
likelihood O
estimation O
tested O
whether O
circadian O
preference O
at O
age O
20 O
predicted O
reward-related O
brain O
function O
in O
the O
mPFC O
and O
VS O
at O
age O
22 O
after O
adjusting O
for O
reward-related O
brain O
function O
at O
age O
20 O
and O
circadian O
preference O
at O
age O
22 O
. O

Analyses O
were O
performed O
separately O
for O
reward O
anticipation O
and O
win O
outcome O
responses O
. O

Given O
prior O
reports O
that O
depressive O
symptoms O
are O
associated O
with O
both O
eveningness O
and O
reward-related O
brain O
function O
, O
we O
initially O
added O
BDI O
scores O
at O
age O
20 O
and O
22 O
to O
the O
cross-lag O
models O
. O

Parameter O
estimates O
were O
generated O
for O
autocorrelations O
( O
e.g. O
, O
longitudinal O
path O
of O
one O
variable O
on O
itself O
) O
, O
cross-lag O
relationships O
( O
e.g. O
, O
longitudinal O
path O
of O
one O
variable O
on O
another O
variable O
) O
, O
and O
concurrent O
correlations O
between O
variables O
at O
each O
assessment O
point O
. O

This O
model O
resulted O
in O
zero O
degrees O
of O
freedom O
( O
a O
just-identified O
model O
) O
, O
therefore O
, O
goodness-of-fit O
could O
not O
be O
evaluated O
. O

Mediation O
analyses O
tested O
whether O
associations O
between O
circadian O
preference O
at O
age O
20 O
and O
substance O
involvement O
at O
age O
22 O
were O
mediated O
through O
reward-related O
brain O
function O
in O
the O
mPFC O
and O
VS O
at O
age O
22 O
. O

Analyses O
were O
performed O
separately O
for O
alcohol O
dependence O
, O
frequency O
of O
alcohol O
use O
, O
and O
frequency O
of O
cannabis O
use O
. O

Parameter O
estimates O
were O
generated O
for O
autocorrelations O
; O
cross-lag O
relationships O
of O
endogenous O
age O
22 O
variables O
on O
age O
20 O
circadian O
preference O
; O
concurrent O
correlations O
between O
mPFC O
and O
VS O
response O
at O
ages O
20 O
and O
22 O
; O
concurrent O
correlations O
between O
circadian O
preference O
and O
substance O
involvement O
at O
age O
22 O
; O
and O
regressions O
of O
age O
22 O
substance O
involvement O
on O
concurrent O
mPFC O
and O
VS O
response O
. O

Model O
goodness-of-fit O
was O
evaluated O
using O
absolute O
indices O
( O
i.e. O
, O
χ2 O
, O
RMSEA O
, O
SRMR O
) O
and O
comparative O
indices O
( O
i.e. O
, O
CFI O
, O
TLI O
) O
. O

Indirect O
effects O
were O
calculated O
using O
95 O
% O
two-tailed O
, O
bias-corrected O
bootstrap O
confidence O
intervals O
. O

In O
addition O
, O
because O
smoking O
on O
the O
day O
of O
the O
scan O
may O
affect O
brain O
blood O
flow O
and O
is O
associated O
with O
other O
substance O
use O
, O
we O
performed O
supplemental O
analyses O
that O
included O
a O
dichotomous O
indicator O
of O
daily O
smoking O
( O
yes O
, O
no O
) O
as O
a O
covariate O
in O
mediation O
analyses O
. O

Including O
the O
daily O
smoking O
covariate O
did O
not O
substantially O
alter O
the O
results O
of O
mediation O
analyses O
( O
see O
Figures O
S3 O
and O
S4 O
of O
the O
Supplement O
) O
; O
results O
without O
the O
daily O
smoking O
covariate O
are O
reported O
here O
. O

